Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014,
Post# of 250601
Posted On: 11/21/2014 3:18:35 AM
Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on OSIR
Small biopharma Osiris jumps after reporting an unexpected profit 11:23 a.m. March 5, 2014 - Russ Britt
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Six stocks with continuing upside 1:50 p.m. Aug. 14, 2013 - The Trading Deck
Osiris keeps losses down, investors reward shares 7:34 p.m. March 6, 2013 - Russ Britt
Osiris Therapeutics down 5% in premarket trades 7:25 a.m. July 3, 2012 - Steve Gelsi
Thursday’s biggest gaining and declining stocks 3:56 p.m. June 21, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:24 p.m. June 18, 2012 - MarketWatch
Osiris gains on New Zealand regulatory approval 11:57 a.m. June 18, 2012 - Val Brickates Kennedy
Osiris: Gov't OKs pass-through status for Grafix 5:44 p.m. May 29, 2012 - MarketWatch.com
Osiris shares rally for second straight session 1:10 p.m. May 21, 2012 - Val Brickates Kennedy
Stocks to watch Friday: Osiris, Autodesk, Marvell 5:49 a.m. May 18, 2012 - MarketWatch
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Osiris up 14% after Canada OKs stem-cell treatment 4:33 p.m. May 17, 2012 - Carla Mozee
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Radiation drug makers lose some ground 11:31 a.m. March 16, 2011 - Russ Britt
Appeals court blocks stem-cell funding ban: AP 2:51 p.m. Sept. 9, 2010 - Val Brickates Kennedy
Stem-cell stocks regain ground 3:13 p.m. Aug. 26, 2010 - Val Brickates Kennedy
Drug stocks trend higher in afternoon action 11:59 a.m. June 24, 2009 - Val Brickates Kennedy
Other News on OSIR
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog 9:00 a.m. Nov. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 10:35 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q3 2014 Results - Earnings Call Transcript 12:00 p.m. Nov. 7, 2014 - Seeking Alpha
Osiris Therapeutics (OSIR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 7, 2014 - Seeking Alpha
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 7:21 a.m. Oct. 24, 2014 - Seeking Alpha
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Update: Osiris Therapeutics Earnings 7:55 a.m. Aug. 15, 2014 - Seeking Alpha
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 10:50 a.m. Aug. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 5:11 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics (OSIR) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 3:50 p.m. July 29, 2014 - GuruFocus.com
Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog 3:45 p.m. July 11, 2014 - Zacks.com
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015 10:56 a.m. July 11, 2014 - Seeking Alpha
Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 8:46 a.m. July 10, 2014 - Zacks.com
BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape 7:44 a.m. July 7, 2014 - Zacks.com
Merge Healthcare: Updated Research Report - Analyst Blog 1:55 p.m. June 20, 2014 - Zacks.com
Illumina: Updated Research Report - Analyst Blog 1:30 p.m. June 20, 2014 - Zacks.com
Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog 12:10 p.m. June 13, 2014 - Zacks.com
Press Releases on OSIR
Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum 8:04 a.m. Nov. 17, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable 8:02 a.m. Nov. 7, 2014 - BusinessWire - BZX
Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment of Chief Financial Officer 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform® 7:01 a.m. Oct. 17, 2014 - BusinessWire - BZX
Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds 7:02 a.m. Oct. 16, 2014 - BusinessWire - BZX
Analysis of the Global Stem Cell Market 2:14 p.m. Oct. 13, 2014 - PR Newswire - PRF
Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call 10:58 a.m. Oct. 13, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa 7:01 a.m. Sept. 25, 2014 - BusinessWire - BZX
Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies 3:16 p.m. Sept. 15, 2014 - BusinessWire - BZX
Grafix® Randomized Controlled Clinical Trial Recognized as High Quality DFU Trial in Recent Wounds Supplement 8:02 a.m. Sept. 11, 2014 - BusinessWire - BZX
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Osiris Therapeutics, Inc. -- OSIR 9:37 a.m. Aug. 14, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter 7:04 a.m. Aug. 7, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically in Peer-Reviewed Journal 3:00 p.m. July 22, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results Conference Call 3:00 p.m. July 14, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference 7:00 a.m. June 20, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Accepted in Peer-Reviewed Journal 7:02 a.m. June 19, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 30, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 6:00 a.m. May 19, 2014 - PR Newswire - PRF
MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecasts 11:33 a.m. May 14, 2014 - PR Newswire - PRF
Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78% 3:01 p.m. May 12, 2014 - BusinessWire - BZX
MarketWatch News on OSIR
Small biopharma Osiris jumps after reporting an unexpected profit 11:23 a.m. March 5, 2014 - Russ Britt
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Six stocks with continuing upside 1:50 p.m. Aug. 14, 2013 - The Trading Deck
Osiris keeps losses down, investors reward shares 7:34 p.m. March 6, 2013 - Russ Britt
Osiris Therapeutics down 5% in premarket trades 7:25 a.m. July 3, 2012 - Steve Gelsi
Thursday’s biggest gaining and declining stocks 3:56 p.m. June 21, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:24 p.m. June 18, 2012 - MarketWatch
Osiris gains on New Zealand regulatory approval 11:57 a.m. June 18, 2012 - Val Brickates Kennedy
Osiris: Gov't OKs pass-through status for Grafix 5:44 p.m. May 29, 2012 - MarketWatch.com
Osiris shares rally for second straight session 1:10 p.m. May 21, 2012 - Val Brickates Kennedy
Stocks to watch Friday: Osiris, Autodesk, Marvell 5:49 a.m. May 18, 2012 - MarketWatch
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Osiris up 14% after Canada OKs stem-cell treatment 4:33 p.m. May 17, 2012 - Carla Mozee
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Radiation drug makers lose some ground 11:31 a.m. March 16, 2011 - Russ Britt
Appeals court blocks stem-cell funding ban: AP 2:51 p.m. Sept. 9, 2010 - Val Brickates Kennedy
Stem-cell stocks regain ground 3:13 p.m. Aug. 26, 2010 - Val Brickates Kennedy
Drug stocks trend higher in afternoon action 11:59 a.m. June 24, 2009 - Val Brickates Kennedy
Other News on OSIR
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog 9:00 a.m. Nov. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 10:35 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q3 2014 Results - Earnings Call Transcript 12:00 p.m. Nov. 7, 2014 - Seeking Alpha
Osiris Therapeutics (OSIR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 7, 2014 - Seeking Alpha
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 7:21 a.m. Oct. 24, 2014 - Seeking Alpha
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Update: Osiris Therapeutics Earnings 7:55 a.m. Aug. 15, 2014 - Seeking Alpha
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 10:50 a.m. Aug. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 5:11 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics (OSIR) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 3:50 p.m. July 29, 2014 - GuruFocus.com
Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog 3:45 p.m. July 11, 2014 - Zacks.com
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015 10:56 a.m. July 11, 2014 - Seeking Alpha
Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 8:46 a.m. July 10, 2014 - Zacks.com
BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape 7:44 a.m. July 7, 2014 - Zacks.com
Merge Healthcare: Updated Research Report - Analyst Blog 1:55 p.m. June 20, 2014 - Zacks.com
Illumina: Updated Research Report - Analyst Blog 1:30 p.m. June 20, 2014 - Zacks.com
Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog 12:10 p.m. June 13, 2014 - Zacks.com
Press Releases on OSIR
Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum 8:04 a.m. Nov. 17, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable 8:02 a.m. Nov. 7, 2014 - BusinessWire - BZX
Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment of Chief Financial Officer 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform® 7:01 a.m. Oct. 17, 2014 - BusinessWire - BZX
Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds 7:02 a.m. Oct. 16, 2014 - BusinessWire - BZX
Analysis of the Global Stem Cell Market 2:14 p.m. Oct. 13, 2014 - PR Newswire - PRF
Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call 10:58 a.m. Oct. 13, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa 7:01 a.m. Sept. 25, 2014 - BusinessWire - BZX
Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies 3:16 p.m. Sept. 15, 2014 - BusinessWire - BZX
Grafix® Randomized Controlled Clinical Trial Recognized as High Quality DFU Trial in Recent Wounds Supplement 8:02 a.m. Sept. 11, 2014 - BusinessWire - BZX
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Osiris Therapeutics, Inc. -- OSIR 9:37 a.m. Aug. 14, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter 7:04 a.m. Aug. 7, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically in Peer-Reviewed Journal 3:00 p.m. July 22, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results Conference Call 3:00 p.m. July 14, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference 7:00 a.m. June 20, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Accepted in Peer-Reviewed Journal 7:02 a.m. June 19, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 30, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 6:00 a.m. May 19, 2014 - PR Newswire - PRF
MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecasts 11:33 a.m. May 14, 2014 - PR Newswire - PRF
Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78% 3:01 p.m. May 12, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼